BMO Capital Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform, 'Current Valuation Skews Risk/Reward to Upside'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. RDDT
4. SNDK
5. SPY
6. HTFL
7. ADYEN:NA
8. ADYYF
9. TPR
10. DGNX

Go back to BMO Capital Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform, 'Current Valuation Skews Risk/Reward to Upside'

BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $104 at Canaccord Genuity

July 3, 2023 6:13 AM EDT

Canaccord Genuity analyst Whitney Ijem lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $104.00 (from $110.00) while maintaining a Hold rating.... More

Increasing unusual put option volume: BMRN EBIX SCCO EOSE BBIO OSTK CAVA

July 3, 2023 4:49 AM EDT

Increasing unusual put option volume: BMRN EBIX SCCO EOSE BBIO OSTK CAVA

... More